|
2024
|
G/S
|
Educational services, namely, providing classes, seminars, and workshops in the fields of medicat... |
|
|
G/S
|
Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, be... |
|
|
G/S
|
Pharmaceuticals and medicines for the treatment of cystic
fibrosis, pain, sickle cell disease, b... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cystic fibrosis. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cystic
fibrosis. |
|
2023
|
Invention
|
Re-aggregation of stem cell-derived pancreatic beta cells.
The present application discloses cel... |
|
|
Invention
|
Differentiation of pancreatic endocrine cells.
Disclosed herein are compositions and methods rel... |
|
|
G/S
|
Pharmaceuticals and medical treatment products in the field of diabetes; cell therapy products fo... |
|
|
G/S
|
Pharmaceuticals and medical treatments in the field of
diabetes; cell therapy products for medic... |
|
|
G/S
|
Pharmaceuticals and medical treatment products in the field
of diabetes; cell therapy products f... |
|
|
G/S
|
Pharmaceuticals and medical treatments in the field of diabetes; cell therapy products for medica... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cystic fibrosis |
|
|
G/S
|
medical and scientific research; medical and scientific research in the field of gene therapy; me... |
|
|
Invention
|
Cell housing device.
The present disclosure provides a cell housing device and a method of manuf... |
|
|
Invention
|
Enhanced differentiation of pancreatic islet cells. Disclosed herein are compositions and methods... |
|
|
Invention
|
Materials and methods for treatment of pain related disorders.
The present application provides ... |
|
|
Invention
|
Modulators of alpha-1 antitrypsin. Novel compounds, compositions, and methods of using and prepar... |
|
|
G/S
|
Providing on-line non-downloadable software for use by healthcare professionals to view and acces... |
|
|
Invention
|
Nucleic acid encoding modified membrane type serine protease 1 (mtsp-1) polypeptides and methods ... |
|
|
G/S
|
Providing health information in the field of sickle cell disease; providing health care informati... |
|
|
Invention
|
Compositions for the treatment of cftr-mediated diseases. RNN-[2,4-Bis(1,1-dimethylethyl)-5-hydro... |
|
|
G/S
|
Providing information in the field of gene editing technology; Providing medical and scientific r... |
|
|
Invention
|
Tandem guide rnas (tg-rnas) and their use in genome editing. Compositions comprising tandem gRNAs... |
|
|
G/S
|
Pharmaceutical preparations for treating diabetes; medical treatments in the nature of anti-diabe... |
|
|
Invention
|
Factor b proteases.
Provided herein are engineered proteases of the S1A family that are specific... |
|
|
Invention
|
Macroencapsulation devices. A method of manufacturing a macroencapsulation device includes aligni... |
|
|
Invention
|
Macroencapsulation devices.
A method of manufacturing a macroencapsulation device includes align... |
|
|
Invention
|
Methods of treatment for cystic fibrosis. This disclosure provides methods of treating cystic fib... |
|
|
Invention
|
Solid forms of a macrocyclic compounds as cftr modulators and their preparation. Processes and me... |
|
|
Invention
|
Complement factor i dosing regimens for treating ocular diseases. Provided herein are dosing regi... |
|
|
Invention
|
Heteroaryl compounds for the treatment of pain.
Compounds, and pharmaceutically acceptable salts... |
|
|
Invention
|
Heteroaryl compounds for the treatment of pain. Compounds, and pharmaceutically acceptable salts ... |
|
|
G/S
|
Educational services, namely, providing classes, seminars,
and workshops in the fields of medica... |
|
|
G/S
|
Providing online non-downloadable software featuring a
portal for order management and maintaini... |
|
|
G/S
|
Providing online non-downloadable software featuring a portal for order management and maintainin... |
|
|
Invention
|
Compositions and methods for enhancing aav therapy and decreasing tropism of aav to the liver. Co... |
|
|
Invention
|
Modulators of cystic fibrosis transmembrane conductance regulator. This disclosure provides modul... |
|
|
Invention
|
Precise excisions of portions of exons for treatment of duchenne muscular dystrophy. Compositions... |
|
|
Invention
|
Precise excisions of portions of exon 44, 50, and 53 for treatment of duchenne muscular dystrophy... |
|
|
Invention
|
Modulators of atp-binding cassette transporters.
Compounds of the present invention and pharmace... |
|
|
Invention
|
Cell therapy for diabetes.
Disclosed herein are compositions, kits, and methods related to cell ... |
|
|
Invention
|
Process of making cftr modulators.
The disclosure provides processes for synthesizing Compound I... |
|
2022
|
Invention
|
Pharmaceutical compositions for the treatment of cftr mediated diseases.
Pharmaceutical composit... |
|
|
Invention
|
Carboxamides as modulators of sodium channels.
Compounds, and pharmaceutically acceptable salts ... |
|
|
Invention
|
Pteridinone compounds and uses thereof.
The present invention provides compounds of Formula I, o... |
|
|
Invention
|
Solid forms of (r)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-... |
|
|
Invention
|
Substituted tetrahydrofurans as modulators of sodium channels. Compounds, and pharmaceutically ac... |
|
|
G/S
|
Providing medical and scientific research information in the field of cell therapy; providing pha... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations pri... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of blood
disorders; pharmaceutical preparations pr... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations pri... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of genetic disorders. Providing medical and scienti... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of genetic disorders Providing medical and scientif... |
|
|
Invention
|
Processes for making modulators of cystic fibrosis transmembrane conductance regulator.
The disc... |
|
|
Invention
|
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions... |
|
|
G/S
|
Pharmaceutical preparations for human use. |
|
2021
|
Invention
|
Solid forms of 4-(5-(4-fluorophenyl)-6-(tetrahydro-2h-pyran-4-yl)-1,5-dihydropyrrolo[2,3-f]indazo... |
|
|
Invention
|
Methods of monitoring alpha-1 antitrypsin (aat) deficiency by measuring polymerised aat.
This ap... |
|
|
Invention
|
Compositions and methods for treatment of dm1 with slucas9 and sacas9.
Compositions and methods ... |
|
|
Invention
|
Modulators of cystic fibrosis transmembrane conductance regulator.
This disclosure provides modu... |
|
|
Invention
|
Crystalline forms of cftr modulators.
Crystalline forms of salts of Compound I are disclosed. Ph... |
|
|
Invention
|
Modulators of alpha-1 antitrypsin.
Novel compounds, compositions, and methods of using and prepa... |
